We furnish expert opinion and produce an odds estimate predicting success for the reimbursement of new technologies.
It is particularly important for investors to have a clear picture of the complexity surrounding reimbursement issues. Innovative technology in itself is not enough ! Without a positive reimbursement status, the chances for establishing a novel technology in the health care market are small.